300 related articles for article (PubMed ID: 32121192)
1. Recent Advances in the Use of Plant Virus-Like Particles as Vaccines.
Balke I; Zeltins A
Viruses; 2020 Feb; 12(3):. PubMed ID: 32121192
[TBL] [Abstract][Full Text] [Related]
2. Use of plant viruses and virus-like particles for the creation of novel vaccines.
Balke I; Zeltins A
Adv Drug Deliv Rev; 2019 May; 145():119-129. PubMed ID: 30172923
[TBL] [Abstract][Full Text] [Related]
3. Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.
Narayanan KB; Han SS
Virus Genes; 2018 Oct; 54(5):623-637. PubMed ID: 30008053
[TBL] [Abstract][Full Text] [Related]
4. Virus like particle-based vaccines against emerging infectious disease viruses.
Liu J; Dai S; Wang M; Hu Z; Wang H; Deng F
Virol Sin; 2016 Aug; 31(4):279-87. PubMed ID: 27405928
[TBL] [Abstract][Full Text] [Related]
5. Enveloped virus-like particle platforms: vaccines of the future?
Pitoiset F; Vazquez T; Bellier B
Expert Rev Vaccines; 2015 Jul; 14(7):913-5. PubMed ID: 25968245
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Dendritic Cell Activation by Virus-Based Vaccine Delivery Vectors Emphasizes the Transcriptional Downregulation of the Oxidative Phosphorylation Pathway.
Tsitoura E; Kazazi D; Oz-Arslan D; Sever EA; Khalili S; Vassilaki N; Aslanoglou E; Dérian N; Six A; Sezerman OU; Klatzmann D; Mavromara P
Hum Gene Ther; 2019 Apr; 30(4):429-445. PubMed ID: 30351174
[TBL] [Abstract][Full Text] [Related]
7. Virus-like particles: promising platforms with characteristics of DIVA for veterinary vaccine design.
Liu F; Wu X; Li L; Ge S; Liu Z; Wang Z
Comp Immunol Microbiol Infect Dis; 2013 Jul; 36(4):343-52. PubMed ID: 23561290
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
9. Prokaryotic Production of Virus-Like Particle Vaccine of Betanodavirus.
Xie J; Huang R; Lai Y
Methods Mol Biol; 2016; 1404():211-223. PubMed ID: 27076301
[TBL] [Abstract][Full Text] [Related]
10. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
11. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
[TBL] [Abstract][Full Text] [Related]
12. The 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics".
Mohsen MO; Augusto G; Bachmann MF
Immunol Rev; 2020 Jul; 296(1):155-168. PubMed ID: 32472710
[TBL] [Abstract][Full Text] [Related]
13. Current status and future directions of fish vaccines employing virus-like particles.
Jeong KH; Kim HJ; Kim HJ
Fish Shellfish Immunol; 2020 May; 100():49-57. PubMed ID: 32130976
[TBL] [Abstract][Full Text] [Related]
14. Virus-like particles: the new frontier of vaccines for animal viral infections.
Crisci E; Bárcena J; Montoya M
Vet Immunol Immunopathol; 2012 Aug; 148(3-4):211-25. PubMed ID: 22705417
[TBL] [Abstract][Full Text] [Related]
15. Parainfluenza virus 5-vectored vaccines against human and animal infectious diseases.
Chen Z
Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29316047
[TBL] [Abstract][Full Text] [Related]
16. Engineering virus-like particles as vaccine platforms.
Frietze KM; Peabody DS; Chackerian B
Curr Opin Virol; 2016 Jun; 18():44-9. PubMed ID: 27039982
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology.
Bello MB; Yusoff K; Ideris A; Hair-Bejo M; Jibril AH; Peeters BPH; Omar AR
Viruses; 2020 Apr; 12(4):. PubMed ID: 32316317
[TBL] [Abstract][Full Text] [Related]
18. Designing Chimeric Virus-like Particle-based Vaccines for Human Papillomavirus and HIV: Lessons Learned.
Eto Y; Saubi N; Ferrer P; Joseph J
AIDS Rev; 2019; 21(4):218-232. PubMed ID: 31834327
[TBL] [Abstract][Full Text] [Related]
19. Virus-Like Particle Vaccines Against Respiratory Viruses and Protozoan Parasites.
Chu KB; Quan FS
Curr Top Microbiol Immunol; 2021; 433():77-106. PubMed ID: 33650036
[TBL] [Abstract][Full Text] [Related]
20. Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines.
Caldeira JC; Perrine M; Pericle F; Cavallo F
Viruses; 2020 Apr; 12(5):. PubMed ID: 32349216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
